Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Nov 14;120(6):1275-1284.
doi: 10.14309/ajg.0000000000003213.

Predictors of Outcomes After Gastric Peroral Endoscopic Myotomy for Refractory Gastroparesis: A Systematic Review

Chris Varghese  1 , Alexandria Lim  1 , Charlotte Daker  2 , Gabrielle Sebaratnam  1 , Armen A Gharibans  1   3   4   5 , Christopher N Andrews  6 , William L Hasler  7 , Greg O'Grady  1   3   4 ; BSM Consortium and GPOEM-GEMS Study Group*
Collaborators, Affiliations

Predictors of Outcomes After Gastric Peroral Endoscopic Myotomy for Refractory Gastroparesis: A Systematic Review

Chris Varghese et al. Am J Gastroenterol. .

Abstract

Introduction: Gastroparesis is a debilitating gastroduodenal disorder for which gastric peroral endoscopic myotomy (GPOEM) has emerged as an efficacious treatment option. However, response to GPOEM varies between 50% and 80%, such that preoperative predictors of treatment success are needed to guide patient selection.

Methods: We performed a systematic review to identify predictors of clinical and functional response to GPOEM among adult patients with gastroparesis (PROSPERO: CRD42023457359). MEDLINE, Embase, and CENTRAL databases were searched systematically for studies reporting outcomes after GPOEM in September 2023. A narrative synthesis of predictive factors on univariable and multivariable analysis was performed with consideration of response rates through meta-analysis and evaluation of discrimination if prognostic models were developed. Risk Of Bias In Non-randomized Studies - of Exposures (ROBINS-E) was used for risk of bias assessment.

Results: Of 1899 articles reviewed, 30 were included. The GPOEM response rate was 63.1% (95% confidence interval 56.3%-69.5%) with most studies defining clinical success on the basis of improvement in gastroparesis cardinal symptom index (87%, 26/30). Older age, shorter duration of gastroparesis, nondiabetic etiology, lower body mass index, and response to intrapyloric botulinum toxin were associated with positive response to GPOEM on multivariable analyses. Predictors on physiological tests such as EndoFLIP or gastric emptying scintigraphy were inconsistent. No prognostic models underwent external validation.

Discussion: Currently, there are limited reproducible predictors of response to GPOEM among patients with refractory gastroparesis. Robust prospective studies investigating scalable, reproducible, and actionable biomarkers of treatment response are required.

Keywords: GPOEM; endoscopy; gastroparesis; predictors.

PubMed Disclaimer

References

    1. Camilleri M, Kuo B, Nguyen L, et al. ACG clinical guideline: Gastroparesis. Am J Gastroenterol 2022;117(8):1197–220.
    1. Parkman HP, Wilson LA, Yates KP, et al. Factors that contribute to the impairment of quality of life in gastroparesis. Neurogastroenterol Motil 2021;33(8):e14087.
    1. Wadhwa V, Mehta D, Jobanputra Y, et al. Healthcare utilization and costs associated with gastroparesis. World J Gastroenterol 2017;23(24):4428–36.
    1. Yu D, Ramsey FV, Norton WF, et al. The burdens, concerns, and quality of life of patients with gastroparesis. Dig Dis Sci 2017;62(4):879–93.
    1. Chen YJ, Tang W, Ionescu-Ittu R, et al. Health-care resource use and costs associated with diabetic and idiopathic gastroparesis: A claims analysis of the first 3 years following the diagnosis of gastroparesis. Neurogastroenterol Motil 2022;34(9):e14366.

Publication types